Patients with kidney and prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

Prostate Kidney Cell Line, Tumor Tumor Cells, Cultured Kidney Tubules Kidney Cortex Epithelial Cells Kidney Glomerulus Neoplastic Stem Cells Chromosomes, Human, Pair 8 Kidney Tubules, Proximal Kidney Medulla Seminal Vesicles Cell Line Rectum Stromal Cells Neoplastic Cells, Circulating Cell Nucleus

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases37

Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Disease Progression Kidney Diseases Neoplasm Metastasis Adenocarcinoma Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Carcinoma Lung Neoplasms Neoplasm Recurrence, Local Kidney Neoplasms Prostatic Neoplasms, Castration-Resistant Ovarian Neoplasms Acute Kidney Injury Colonic Neoplasms Kidney Failure, Chronic Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Disease Models, Animal Prostatitis Pancreatic Neoplasms Polycystic Kidney Diseases Urinary Bladder Neoplasms Neovascularization, Pathologic Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Kidney Calculi

Chemicals and Drugs67

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds RNA, Messenger Antineoplastic Agents Antineoplastic Agents, Hormonal Androgen Receptor Antagonists Neoplasm Proteins Anilides Dihydrotestosterone Finasteride Metribolone RNA, Small Interfering Flutamide Anticarcinogenic Agents Cancer Vaccines Taxoids Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors DNA, Neoplasm PTEN Phosphohydrolase Testosterone Congeners Antigens, Neoplasm Antineoplastic Agents, Phytogenic Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Nitriles Azasteroids Proto-Oncogene Proteins c-akt Phenylthiohydantoin Transcription Factors Tumor Suppressor Protein p53 RNA, Neoplasm Racemases and Epimerases MicroRNAs Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase Estramustine Leuprolide Receptor, erbB-2 Goserelin DNA-Binding Proteins Glutathione S-Transferase pi Enzyme Inhibitors Antibodies, Monoclonal Receptors, Estrogen DNA Primers Proto-Oncogene Proteins Kallikreins Proto-Oncogene Proteins c-bcl-2 Prostatic Secretory Proteins Androgen-Binding Protein Membrane Proteins Steroid 17-alpha-Hydroxylase Paclitaxel Oncogene Proteins, Fusion Insulin-Like Growth Factor Binding Protein 3 Cadherins Carotenoids Nuclear Proteins Ki-67 Antigen Receptor, Epidermal Growth Factor Trans-Activators

Analytical, Diagnostic and Therapeutic Techniques and Equipment75

Prostatectomy Orchiectomy Early Detection of Cancer Kidney Transplantation Neoplasm Grading Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Risk Factors Prognosis Xenograft Model Antitumor Assays Digital Rectal Examination Immunohistochemistry Neoplasm Transplantation Transplantation, Heterologous Blotting, Western Case-Control Studies Gene Expression Profiling Follow-Up Studies Prospective Studies Risk Retrospective Studies Biopsy Transurethral Resection of Prostate Risk Assessment Survival Rate Survival Analysis Sensitivity and Specificity Treatment Outcome Incidence Biopsy, Needle Transfection Cohort Studies Odds Ratio Brachytherapy Oligonucleotide Array Sequence Analysis Tumor Burden Predictive Value of Tests Combined Modality Therapy Tissue Array Analysis Multivariate Analysis Disease-Free Survival Registries Castration Polymerase Chain Reaction SEER Program Antineoplastic Combined Chemotherapy Protocols Radiotherapy Kaplan-Meier Estimate Logistic Models Disease Models, Animal Reproducibility of Results Nomograms Molecular Targeted Therapy Radiotherapy Dosage Drug Screening Assays, Antitumor Models, Biological Radiotherapy, Conformal Questionnaires Kidney Function Tests Immunoenzyme Techniques Mass Screening Confidence Intervals Gene Knockdown Techniques Clinical Trials as Topic Flow Cytometry In Situ Hybridization, Fluorescence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Proportional Hazards Models ROC Curve Real-Time Polymerase Chain Reaction Immunoblotting Chemotherapy, Adjuvant Immunotherapy Genetic Therapy

Psychiatry and Psychology1

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Signal Transduction Risk Cell Growth Processes Down-Regulation Sensitivity and Specificity Drug Resistance, Neoplasm Cell Division Genotype Time Factors Cell Survival Transfection Odds Ratio Cell Movement Up-Regulation Dose-Response Relationship, Drug Promoter Regions, Genetic DNA Methylation Mutation Polymorphism, Genetic Cell Cycle Base Sequence Gene Expression Gene Silencing Nomograms Gene Fusion RNA Interference Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Phosphorylation Diet Transcription, Genetic Polymorphism, Single Nucleotide Tissue Distribution Alleles Phenotype Genes, Neoplasm Germ-Line Mutation Drug Synergism Amino Acid Sequence

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries SEER Program Molecular Sequence Data Base Sequence Radiotherapy, Conformal Questionnaires Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Amino Acid Sequence

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care32

Risk Factors Watchful Waiting Case-Control Studies Follow-Up Studies Prospective Studies Risk Retrospective Studies Risk Assessment Survival Rate Survival Analysis Sensitivity and Specificity Treatment Outcome Incidence Cohort Studies Odds Ratio Age Factors Predictive Value of Tests Multivariate Analysis Disease-Free Survival Registries SEER Program National Cancer Institute (U.S.)Kaplan-Meier Estimate Logistic Models Reproducibility of Results Nomograms Questionnaires Mass Screening Confidence Intervals Clinical Trials as Topic Proportional Hazards Models ROC Curve

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostate Prostatic Neoplasms Prostate-Specific Antigen Kidney Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Disease Progression Kidney Diseases Tumor Markers, Biological Mice, Nude Neoplasm Metastasis Adenocarcinoma Prostatic Intraepithelial Neoplasia Tosyl Compounds Kidney Transplantation Bone Neoplasms Neoplasm Invasiveness Neoplasm Grading Cell Proliferation Neoplasm Staging Apoptosis Tumor Cells, Cultured Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Antineoplastic Agents Antineoplastic Agents, Hormonal Genetic Predisposition to Disease Risk Factors Prognosis Androgen Receptor Antagonists Neoplasm Proteins Xenograft Model Antitumor Assays Digital Rectal Examination Anilides Immunohistochemistry Neoplasm Transplantation Watchful Waiting Dihydrotestosterone Transplantation, Heterologous Blotting, Western Breast Neoplasms Kidney Tubules Finasteride Neoplasms Case-Control Studies Gene Expression Profiling Signal Transduction Follow-Up Studies Prospective Studies Risk Retrospective Studies Biopsy Carcinoma Metribolone Transurethral Resection of Prostate Risk Assessment Lung Neoplasms Survival Rate Kidney Cortex Cell Growth Processes Neoplasm Recurrence, Local RNA, Small Interfering Down-Regulation Survival Analysis United States Sensitivity and Specificity Kidney Neoplasms Drug Resistance, Neoplasm Treatment Outcome Flutamide Prostatic Neoplasms, Castration-Resistant Ovarian Neoplasms Anticarcinogenic Agents Cell Division Genotype Time Factors Cell Survival Cancer Vaccines Acute Kidney Injury Taxoids Incidence Glutamate Carboxypeptidase II Biopsy, Needle Transfection Cohort Studies Mice, SCID Colonic Neoplasms Odds Ratio 5-alpha Reductase Inhibitors Cell Movement DNA, Neoplasm PTEN Phosphohydrolase

No FAQ available that match "patients with kidney and prostate cancer"